CORC

在结果中检索

CORC

浏览/检索结果: 共67条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Unraveling the Therapeutic Mechanism of Saussurea involucrata against Rheumatoid Arthritis: A Network Pharmacology and Molecular Modeling-Based Investigation 期刊论文
NUTRIENTS, 2023, 卷号: 15, 期号: 19
作者:  Chen, Jinghua;  Wu, Xiaoke;  Yu, Ruitao
收藏  |  浏览/下载：6/0  |  提交时间：2023/12/01
Inokosterone Is A Potential Drug Target of Estrogen Receptor 1 in Rheumatoid Arthritis Patients: Analysis from Active Ingredient of Cyathula Officinalis 期刊论文
CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2021
作者:  Mo, Ji-hao;  Xie, Han-kun;  Zhou, Ye-mian;  Ng, Sihan-benjamin;  Li, Shao-xia
收藏  |  浏览/下载：18/0  |  提交时间：2021/11/01
Comprehensive screening and separation of cyclooxygenase-2 inhibitors from Pterocephalus hookeri by affinity solid-phase extraction coupled with preparative high-performance liquid chromatography 期刊论文
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2021, 卷号: 1183
作者:  Zhu, Yunhe;  Wang, Weidong;  Liu, Zenggen;  Jiang, Sirong;  Tao, Yanduo
收藏  |  浏览/下载：41/0  |  提交时间：2021/11/18
leflunomideincreasedtherenalexposureofacyclovirbyinhibitingoat13andmrp2 期刊论文
actapharmacologicasinica, 2020, 卷号: 41, 期号: 1, 页码: 129
作者:  Liao Xiaoying;  Deng Qiangqiang;  Han Li;  Wu Zhitao;  Peng Zhaoliang
收藏  |  浏览/下载：86/0  |  提交时间：2020/07/01
Leflunomide increased the renal exposure of acyclovir by inhibiting OAT1/3 and MRP2 期刊论文
ACTA PHARMACOLOGICA SINICA, 2020, 卷号: 41, 期号: 1, 页码: 129-137
作者:  Liao, Xiao-ying;  Deng, Qiang-qiang;  Han, Li;  Wu, Zhi-tao;  Peng, Zhao-liang
收藏  |  浏览/下载：55/0  |  提交时间：2020/07/01
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:  Bi, L.;  Li, Y.;  He, L.;  Xu, H.;  Jiang, Z.
收藏  |  浏览/下载：15/0  |  提交时间：2019/12/04
A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL ACTIVE-CONTROLLED CLINICAL TRIAL COMPARING PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY AND EXPLORATORY EFFICACY BETWEEN HLX01 AND EUROPE-SOURCED RITUXIMAB AS A NEW INDICATION IN CHINESE MODERATE TO SEVERE PATIENTS WITH RHEUMATOID ARTHRITIS 期刊论文
ANNALS OF THE RHEUMATIC DISEASES, 2019, 卷号: 78
作者:  Qiu, Wenting;  Chai, Katherine;  Guo, Xinjun;  Zhang, Xin;  Liu, Eugene
收藏  |  浏览/下载：59/0  |  提交时间：2019/12/04
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:  Bi, L.;  Li, Y.;  He, L.;  Xu, H.;  Jiang, Z.
收藏  |  浏览/下载：38/0  |  提交时间：2019/12/05
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:  Li, X.;  Bi, L.;  Li, Y.;  He, L.;  Xu, H.
收藏  |  浏览/下载：18/0  |  提交时间：2019/12/05
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:  Bi, L.;  Li, Y.;  He, L.;  Xu, H.;  Jiang, Z.
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace